METHOTREXATE FOR SYSTEMIC LUPUS-ERYTHEMATOSUS - A RETROSPECTIVE ANALYSIS OF 17 UNSELECTED CASES

被引：0

作者：

WILKE, WS ^{[1
]}

KRALL, PL ^{[1
]}

SCHEETZ, RJ ^{[1
]}

BABIAK, T ^{[1
]}

DANAO, T ^{[1
]}

MAZANEC, DJ ^{[1
]}

SEGAL, AM ^{[1
]}

CLOUGH, JD ^{[1
]}

机构：

[1] CLEVELAND CLIN FDN,DEPT RHEUMAT & IMMUNOL DIS,CLEVELAND,OH 44195

来源：

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 1991年 / 9卷 / 06期

关键词：

METHOTREXATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY; METHOTREXATE TOXICITY;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report a retrospective study of 17 patients with systemic lupus erythematosus who were treated with oral methotrexate given as a mean weekly dose of 8.47 +/- 1.72 mg. Methotrexate treatment resulted in symptomatic improvement in 57% of patients and allowed the reduction of the mean daily dose of prednisone from 16.66 mg initially to 8.99 mg at one year follow-up. Twelve of 17 patients (70.6%) experienced at least one episode of toxicity. Factors which might be associated with toxicity are analyzed. Because of its potential as a corticosteroid-sparing agent, controlled studies of methotrexate for the treatment of systemic lupus erythematosus are indicated.

引用

页码：581 / 587

页数：7

共 50 条

[21] PROLACTIN IN SYSTEMIC LUPUS-ERYTHEMATOSUS
PAUZNER, R
UROWITZ, MB
GLADMAN, DD
GOUGH, JM
JOURNAL OF RHEUMATOLOGY, 1994, 21 (11) : 2064 - 2067
[22] SYSTEMIC-DISEASE IN SUBACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS - A CONTROLLED COMPARISON WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
COHEN, MR
CROSBY, D
JOURNAL OF RHEUMATOLOGY, 1994, 21 (09) : 1665 - 1669
[23] Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy
Sakthiswary, R.
Suresh, E.
LUPUS, 2014, 23 (03) : 225 - 235
[24] SUCCESSFUL TREATMENT OF INTERSTITIAL LUNG-DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS WITH METHOTREXATE
FINK, SD
KREMER, JM
JOURNAL OF RHEUMATOLOGY, 1995, 22 (05) : 967 - 969
[25] SYSTEMIC LUPUS-ERYTHEMATOSUS RELAPSE WITH LUPUS CYSTITIS
NAKAUCHI, Y
SUEHIRO, T
TAHARA, K
KUMON, Y
YASUOKA, N
OHASHI, Y
KAWADA, M
HASHIMOTO, K
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1995, 13 (05) : 645 - 648
[26] BULLOUS SYSTEMIC LUPUS-ERYTHEMATOSUS - REPORT OF A CASE WITH LUPUS-ERYTHEMATOSUS CELLS IN THE DERMIS
BORRADORI, L
HOHL, D
MONTEIL, M
FRENK, E
DERMATOLOGY, 1993, 187 (04) : 306 - 308
[27] POLIOVACCINES AND THE COURSE OF SYSTEMIC LUPUS-ERYTHEMATOSUS - A RETROSPECTIVE STUDY OF 73 PATIENTS
SCHATTNER, A
BENCHETRIT, E
SCHMILOVITZ, H
VACCINE, 1992, 10 (02) : 98 - 100
[28] CANINE SYSTEMIC LUPUS-ERYTHEMATOSUS .1. A STUDY OF 75 CASES
FOURNEL, C
CHABANNE, L
CAUX, C
FAURE, JR
RIGAL, D
MAGNOL, JP
MONIER, JC
LUPUS, 1992, 1 (03) : 133 - 139
[29] SHRINKING LUNG SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A REPORT OF 3 CASES
SOUBRIER, M
DUBOST, JJ
PIETTE, JC
UROSEVIC, Z
RAMI, S
OUALID, T
RISTORI, JM
BUSSIERE, JL
REVUE DU RHUMATISME, 1995, 62 (05): : 417 - 420
[30] ANTIPHOSPHATIDYLETHANOLAMINE ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
KARMOCHKINE, M
BERARD, M
PIETTE, JC
CACOUB, P
AILLAUD, MF
HARLET, JR
GODEAU, P
BOFFA, MC
LUPUS, 1993, 2 (03) : 157 - 160

← 1 2 3 4 5 →